New Legacy Group, LLC - Q3 2022 holdings

$38.8 Million is the total value of New Legacy Group, LLC's 27 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 3.6% .

 Value Shares↓ Weighting
SellRIVIAN AUTOMOTIVE INC$9,107,000
-48.3%
276,710
-59.6%
23.48%
-34.2%
SPY  SPDR S&P 500 ETF TRtr unit$6,568,000
-5.3%
18,3870.0%16.94%
+20.4%
FB  META PLATFORMS INCcl a$4,145,000
-15.9%
30,5500.0%10.69%
+7.0%
HYG  ISHARES TRiboxx hi yd etf$2,613,000
-3.0%
36,6000.0%6.74%
+23.3%
UBER  UBER TECHNOLOGIES INC$2,006,000
+29.6%
75,6840.0%5.17%
+64.8%
VWO  VANGUARD INTL EQUITY INDEX Fftse emr mkt etf$1,873,000
-12.4%
51,3320.0%4.83%
+11.4%
IWD  ISHARES TRrus 1000 val etf$1,446,000
-6.2%
10,6350.0%3.73%
+19.3%
HEDJ  WISDOMTREE TReurope hedged eq$1,244,000
-5.1%
20,0000.0%3.21%
+20.6%
GLD  SPDR GOLD TR$1,083,000
-8.1%
7,0000.0%2.79%
+16.8%
GVI SellISHARES TRintrm gov cr etf$997,000
-9.2%
9,800
-5.8%
2.57%
+15.4%
MLPX  GLOBAL X FDSglb x mlp enrg i$982,000
-1.6%
26,2000.0%2.53%
+25.1%
AAPL SellAPPLE INC$788,000
-16.4%
5,700
-17.4%
2.03%
+6.3%
IWN  ISHARES TRrus 2000 val etf$774,000
-5.3%
6,0000.0%2.00%
+20.5%
DHS  WISDOMTREE TRus high dividend$758,000
-7.9%
10,0000.0%1.96%
+17.1%
IJR  ISHARES TRcore s&p scp etf$523,000
-5.6%
6,0000.0%1.35%
+20.1%
IGIB  ISHARES TR$435,000
-5.4%
9,0000.0%1.12%
+20.3%
ETY  EATON VANCE TAX-MANAGED DIVE$407,000
-4.2%
37,5000.0%1.05%
+21.8%
IGSB  ISHARES TR$404,000
-2.7%
8,2000.0%1.04%
+23.8%
EFA  ISHARES TRmsci eafe etf$392,000
-10.3%
7,0000.0%1.01%
+14.1%
IEI  ISHARES TR3 7 yr treas bd$389,000
-4.2%
3,4000.0%1.00%
+21.9%
USIG  ISHARES TRusd inv grde etf$365,000
-5.7%
7,6000.0%0.94%
+19.9%
VIG  VANGUARD SPECIALIZED FUNDSdiv app etf$260,000
-5.8%
1,9230.0%0.67%
+19.6%
IGV  ISHARES TRexpanded tech$259,000
-7.2%
1,0350.0%0.67%
+18.0%
XLV  SELECT SECTOR SPDR TRsbi healthcare$248,000
-5.7%
2,0500.0%0.64%
+20.1%
XSW  SPDR SER TR$246,000
-3.5%
2,2990.0%0.63%
+22.6%
IYC  ISHARES TRus consum discre$244,000
+2.5%
4,2000.0%0.63%
+30.2%
XBI  SPDR SER TRs&p biotech$222,000
+6.7%
2,8050.0%0.57%
+35.5%
PHAS ExitPHASEBIO PHARMACEUTICALS INC$0-240,575
-100.0%
-0.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPDR S&P 500 ETF TR8Q3 202321.9%
META PLATFORMS INC8Q3 202322.2%
ISHARES TR8Q3 20238.4%
UBER TECHNOLOGIES INC8Q3 20239.5%
VANGUARD INTL EQUITY INDEX F8Q3 20236.2%
ISHARES TR8Q3 20235.0%
WISDOMTREE TR8Q3 20234.7%
SPDR GOLD TR8Q3 20233.7%
GLOBAL X FDS8Q3 20233.3%
ISHARES TR8Q3 20232.8%

View New Legacy Group, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-08
13F-HR2022-05-16
13F-HR2022-02-14

View New Legacy Group, LLC's complete filings history.

Export New Legacy Group, LLC's holdings